Get the Stockscreener App
3.119
5.05%
0.149
Bone Biologics Corp stock is traded at $3.119, with a volume of 5,718.
It is up +5.05% in the last 24 hours and down -49.68% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$2.97
Open:
$3.02
24h Volume:
5,718
Relative Volume:
0.01
Market Cap:
$1.70M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.4301
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
+5.40%
1M Performance:
-49.68%
6M Performance:
-52.73%
1Y Performance:
-58.40%
1-Day Range:
$2.9787
$3.1287
1-Week Range:
$2.84
$3.1287
52-Week Range:
$2.84
$25.50
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
3.1199 | 4.66M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
124.67 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.39 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
399.56 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.84 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.95 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Bone Biologics Corp Stock (BBLG) Latest News
(BBLGW) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Bone Biologics Corporation Equity Warrant Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
What analysts say about Bone Biologics Corporation stockOverwhelming financial success - printweek.in
Bone Biologics Corporation Stock Analysis and ForecastTriple-digit wealth increases - jammulinksnews.com
What analysts say about Bone Biologics Corporation Equity Warrant stockPhenomenal returns - jammulinksnews.com
What drives Aardvark Therapeutics Inc. stock priceLightning-fast capital gains - jammulinksnews.com
What drives Bone Biologics Corporation stock priceUnprecedented profit potential - jammulinksnews.com
How Austin Gold Corp. stock reacts to Fed policy changesProtected Capital Trading Plan - beatles.ru
Is Bone Biologics Corporation a good long term investmentExceptional return forecasts - jammulinksnews.com
Best Stocks for Value Investors Premium Financial Forecasting ToolsExplosive earning power - jammulinksnews.com
What analysts say about Deluxe Corporation stockBreakthrough stock performance - jammulinksnews.com
What drives Bone Biologics Corporation Equity Warrant stock priceTremendous growth opportunities - jammulinksnews.com
Why NTRA stock is on top investor watchlistsRapid Gain Targets - Newser
Why i3 Verticals Inc. stock attracts strong analyst attentionFree Access to Group - Newser
How Bone Biologics Corporation stock performs during market volatilityROI Driven Alerts - Newser
What makes Bone Biologics Corporation Equity Warrant stock price move sharplyLow Risk ROI Maximization - Newser
What makes Bone Biologics Corporation stock price move sharplyMulti Bagger Alerts - Newser
When ABPWW stock expected to show significant growthIs STEL stock a good long term investment optionFree Best Stocks to Buy Today - Newser
What makes Legato Merger Corp. III stock price move sharplyFree Trading Group - Newser
What makes AGMH stock price move sharplyFree Growth Investment Group - Newser
Why Bone Biologics Corporation stock attracts strong analyst attentionCapital Efficient Investment Tips - Newser
When HOVRW stock expected to show significant growthIs WYNN stock a good long term investment optionTop Analyst Picks - Newser
Why Nu Skin Enterprises Inc. stock attracts strong analyst attentionTechnical Breakout List - Newser
Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy - Business Standard
Bone Biologics (OTC:BBLG) Shares Down 3.6% – Should You Sell? - Defense World
NBSTU SEC FilingsNewbury Street Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Biocon Biologics gets EU nod for two drugs to treat bone diseases - Business Standard
(BBLGW) Long Term Investment Analysis - news.stocktradersdaily.com
Demineralized Bone Matrix Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034) - EIN News
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket - inkl
Bone Biologics Secures $5M Public Offering with Potential for Additional $10M from Warrants - Stock Titan
Penny Stocks Worth WatchingJune 29th - MarketBeat
Bone Biologics (BBLG) Announces $5 Million Public Offering - GuruFocus
BBLG: Making Major Step Toward Commercialization - Research Tree
Pre-market Movers: BBLG, INMB, NAOV, AEMD... - RTTNews
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements - Business Wire
Bone Biologics Regains Nasdaq Compliance After Meeting $1 Bid Price Rule - MarketScreener
Bone Morphogenetic Protein Market Expected to Hit USD 12.3 Billion by 2032 with a Remarkable 5.03% CAGR - industrytoday.co.uk
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading Down 11.7% – Should You Sell? - Defense World
United States shares higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com UK
Bone Biologics (BBLG) Trading Halt Sparks Anticipation | BBLG St - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split By Investing.com - Investing.com South Africa
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BB - GuruFocus
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split - Investing.com
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BBLG Stock News - GuruFocus
Bone Biologics Announces 1-for-6 Reverse Stock Split - Business Wire
Bone Biologics (NASDAQ:BBLG) Trading Down 2.4% – What’s Next? - Defense World
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):